Anúncio
Anúncio

MDCX

MDCX logo

Medicus Pharma Ltd. Common Stock

1.61
USD
Patrocinado
+0.05
+3.27%
09 de jan., 12:27 UTC -5
Abrir

Relatórios de Lucros MDCX

Rácio de surpresa positiva

MDCX separação 2 de 8 últimas estimativas.

25%

Próximo Relatório

Data do Próximo Relatório
23 de mar. de 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/
-$0.11
Mudanças implicadas de Q3 25 (Revenue/ EPS)
--
/
-83.08%
Mudanças implicadas de Q4 24 (Revenue/ EPS)
--
/
-38.89%

Medicus Pharma Ltd. Common Stock earnings per share and revenue

On 14 de nov. de 2025, MDCX reported earnings of -0.65 USD per share (EPS) for Q3 25, missing the estimate of -0.29 USD, resulting in a -119.74% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +4.55% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 6 analistas forecast an EPS of -0.11 USD, with revenue projected to reach -- USD, implying an diminuir of -83.08% EPS, and aumentar of 0.00% in Revenue from the last quarter.
FAQ
For Q3 2025, Medicus Pharma Ltd. Common Stock reported EPS of -$0.65, missing estimates by -119.74%, and revenue of $0.00, 0% as expectations.
The stock price moved up 4.55%, changed from $2.20 before the earnings release to $2.30 the day after.
The next earning report is scheduled for 23 de mar. de 2026.
Based on 6 analistas, Medicus Pharma Ltd. Common Stock is expected to report EPS of -$0.11 and revenue of -- for Q4 2025.
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio